NCT04463095

Brief Summary

Esophageal mucosal changes in long standing achalasia cardia and reversibility after per oral endoscopic myotomy - A pilot study Aims and Objectives:

  • To study mucosal changes in patients with achalasia cardia
  • To study potential malignant histopathological findings in long standing achalasia cardia
  • To assess reversibility of mucosal changes after POEM
  • To study co-relation of mucosal histopathology with predictors of sub-mucosal fibrosis
  • To study muscle biopsy by light microscopy and electron microscopy for viral inclusions Materials and Methods:
  • Study Area - Patients of achalasia cardia undergoing POEM in Asian Institute of Gastroenterology.
  • Study Design - Cross sectional study Inclusion Criteria:
  • All patients of achalasia cardia who will undergo POEM and an esophageal mucosal biopsy at 3 months of follow up Exclusion Criteria:
  • Patients of achalasia cardia not undergoing POEM or an esophageal mucosal biopsy at 3 months of follow up
  • Upper gastro-intestinal surgically altered anatomy ( apart from previous Heller Myotomy )
  • Pregnancy
  • Patients not giving consent for participation
  • End Point( Length of follow up )- 3 months after POEM - single follow up. Study Procedure: Before POEM, all patients will undergo symptom evaluation, esophagogastroduodenoscopy (EGD), high resolution esophageal manometry and timed barium esophagogram.The diagnosis of achalasia will be based on a combination of clinical presentation, esophagogastroduodenoscopy, barium esophagogram and high resolution manometric findings. Symptoms will be classified by using the Eckardt score.Type of Achalasia will be classified according to the Chicago classification. Esophagus shape (sigmoid vs nonsigmoid), presence of hiatus hernia, presence of esophagitis will be assessed on esophagogastroduodenoscopy. Duration since first symptoms of achalasia will be recorded. All patients fulfilling the inclusion criteria will undergo Per Oral Endoscopic Myotomy (POEM). During POEM, a mucosal biopsy and a muscle biopsy of the Esophagus will be taken. Patients will be followed up at a single time, 3 months after POEM. During the follow up visit, patients will undergo esophagogastroduodenoscopy guided mucosal biopsy of the Esophagus. Patients will be divided into two groups based on the duration of symptoms of achalasia- Those having symptoms for 1 year or less and those having symptoms for more than 5 years. Histopathological changes in the Esophagus and reversibility of these changes after POEM will be compared between the two study groups to draw a conclusion.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 12, 2020

Completed
18 days until next milestone

Study Start

First participant enrolled

June 30, 2020

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 9, 2020

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2021

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2021

Completed
Last Updated

April 16, 2024

Status Verified

July 1, 2020

Enrollment Period

6 months

First QC Date

June 12, 2020

Last Update Submit

April 15, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • 1.To study mucosal changes in patients with achalasia cardia

    Number of ganglion cells will be measured in the mucosal biopsy (normal number of ganglion cells are 2 to 12 per mm on Histopathological examination). The size of the ganglion cells will be measured.(normal size of ganglion cells is 10 to 40 microns). Median number of neurons will be measured.(normal median number of neurons are 2 to 6 on histopathological examination).

    12 weeks

  • 2. To study potential malignant histopathological findings in long standing achalasia cardia

    The mean Ki-67 and mean p53 positive ratio will be measured in the histopathological examination.

    12 weeks

Secondary Outcomes (2)

  • 3.To study co-relation of mucosal histopathology with predictors of sub-mucosal fibrosis

    12 weeks

  • 4. To evaluate reversibility of mucosal changes after per oral endoscopic myotomy (POEM )

    12 weeks

Interventions

Peroral endoscopic myotomy (POEM)combines thelong-term efficacy of a myotomy with the benefits of an endoscopic, minimally invasive procedure.Other therapeutic options include endoscopic balloon dilatation and surgical myotomy. Endoscopic balloon dilatation is still widely performed because of its relative non-invasiveness and simplicity, but it has a relatively lower success rate and often requires multiple treatment sessions. Surgical myotomy has been thought to be the curative therapeutic choice for symptomatic achalasia. However, it requires skin incisions and additional anti-reflux surgical intervention.Unlike surgical myotomy, POEM preserves the anatomical integrity of the LES and possibly minimizes postoperative reflux.

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Since the present study is pilot based in assessing the primary outcome, it has been decided to cover 30 patients and follow up at 3 months. Hence no power calculation is used to estimate the sample size.

You may qualify if:

  • All patients of achalasia cardia who will undergo POEM and an esophageal mucosal biopsy at 3 months of follow up

You may not qualify if:

  • Patients of achalasia cardia not undergoing POEM or an esophageal mucosal biopsy at 3 months of follow up
  • Upper gastro-intestinal surgically altered anatomy ( apart from previous Heller Myotomy )
  • Pregnancy
  • Patients not giving consent for participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Asian institute of Gastroenterology/AIG Hospitals

Hyderabad, Telangana, 500082, India

Location

Study Officials

  • Dr Pranav Milind Ambardekar, MBBS MD

    Asian institute of Gastroenterology/AIG Hospitals

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

June 12, 2020

First Posted

July 9, 2020

Study Start

June 30, 2020

Primary Completion

January 1, 2021

Study Completion

September 1, 2021

Last Updated

April 16, 2024

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will not share

Locations